UK markets closed

Mainz Biomed N.V. (MYNZ)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9040-0.0272 (-2.92%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
895.479
895.479
529.877
577.348
493.565
Cost of revenue
385.82
385.82
347.726
399.726
370.48
Gross profit
509.659
509.659
182.151
177.622
123.085
Operating expenses
Research development
9,590
9,590
5,019
481.934
311.851
Selling general and administrative
17,222
17,222
21,452
9,382
450.541
Total operating expenses
27,154
27,154
26,626
9,902
479.386
Operating income or loss
-26,645
-26,645
-26,444
-9,725
-356.301
Interest expense
809.581
809.581
289.324
339.171
268.792
Total other income/expenses net
1,159
1,159
346.028
-1,626
38.198
Income before tax
-26,296
-26,296
-26,387
-11,690
-586.895
Income tax expense
0
0
0
0
0
Income from continuing operations
-26,296
-26,296
-26,387
-11,690
-586.895
Net income
-26,296
-26,296
-26,387
-11,690
-586.895
Net income available to common shareholders
-26,296
-26,296
-26,387
-11,690
-586.895
Basic EPS
-1.92
-1.62
-1.86
-1.62
-0.05
Diluted EPS
-1.92
-1.62
-1.86
-1.62
-0.05
Basic average shares
15,262
16,242
14,157
7,211
11,710
Diluted average shares
15,262
16,242
14,157
7,211
11,710